Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Richard Hockett; Dan Clutter

Premium

CombiMatrix has named Richard Hockett medical director, the firm said last week.

Hockett will start his position in May. He joins CombiMatrix from Affymetrix, where he served as CMO from 1999 to 2008. Before that, he was group leader for genomic medicine at Eli Lilly.

A board certified clinical pathologist, Hockett started his career in the department of pathology at the University of Alabama, Birmingham.

He holds an MD from the University of Minnesota and performed his residency in clinical pathology at Washington University in Saint Louis.


Fluidigm has tapped Dan Clutter as North American sales director for its eastern sales region. He will be responsible for sales growth in the eastern US and Canada and will be a member of Fluidigm's North American commercial leadership team, according to a spokesperson.

Clutter joins Fluidigm from Gentel Biosciences, where he had served as vice president of commercial development since 2009. Before that, he was vice president of sales at NimbleGen Systems, now Roche NimbleGen.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.